Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
1998 1
1999 2
2000 3
2001 2
2002 1
2003 1
2004 3
2005 4
2006 1
2007 3
2008 3
2009 5
2010 4
2011 7
2012 6
2013 5
2014 4
2015 3
2016 12
2017 9
2018 7
2019 8
2020 5
2021 8
Text availability
Article attribute
Article type
Publication date

Search Results

100 results
Results by year
Filters applied: . Clear all
Page 1
Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitope.
Ebrahimi-Nik H, Moussa M, Englander RP, Singhaviranon S, Michaux J, Pak H, Miyadera H, Corwin WL, Keller GLJ, Hagymasi AT, Shcheglova TV, Coukos G, Baker BM, Mandoiu II, Bassani-Sternberg M, Srivastava PK. Ebrahimi-Nik H, et al. Among authors: baker bm. Nat Commun. 2021 Nov 5;12(1):6423. doi: 10.1038/s41467-021-26646-5. Nat Commun. 2021. PMID: 34741035 Free PMC article.
LRRK2 binds to the Rab32 subfamily in a GTP-dependent manner via its armadillo domain.
McGrath E, Waschbüsch D, Baker BM, Khan AR. McGrath E, et al. Among authors: baker bm. Small GTPases. 2021 Mar;12(2):133-146. doi: 10.1080/21541248.2019.1666623. Epub 2019 Sep 25. Small GTPases. 2021. PMID: 31552791 Free PMC article.
LRRK2 is a multi-domain Ser/Thr kinase that is associated with inherited and sporadic cases of Parkinson's disease. Many mutations linked to disease are associated within a central ROC-COR regulatory region and the subsequent kinase domain, leading to enhanced catalytic ac …
LRRK2 is a multi-domain Ser/Thr kinase that is associated with inherited and sporadic cases of Parkinson's disease. Many mutations li …
Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoediting.
Schmidt J, Smith AR, Magnin M, Racle J, Devlin JR, Bobisse S, Cesbron J, Bonnet V, Carmona SJ, Huber F, Ciriello G, Speiser DE, Bassani-Sternberg M, Coukos G, Baker BM, Harari A, Gfeller D. Schmidt J, et al. Among authors: baker bm. Cell Rep Med. 2021 Feb 6;2(2):100194. doi: 10.1016/j.xcrm.2021.100194. eCollection 2021 Feb 16. Cell Rep Med. 2021. PMID: 33665637 Free PMC article.
An Engineered T Cell Receptor Variant Realizes the Limits of Functional Binding Modes.
Singh NK, Alonso JA, Harris DT, Anderson SD, Ma J, Hellman LM, Rosenberg AM, Kolawole EM, Evavold BD, Kranz DM, Baker BM. Singh NK, et al. Among authors: baker bm. Biochemistry. 2020 Nov 3;59(43):4163-4175. doi: 10.1021/acs.biochem.0c00689. Epub 2020 Oct 19. Biochemistry. 2020. PMID: 33074657 Free PMC article.
100 results